280 related articles for article (PubMed ID: 32205749)
1. Hyperdiluted Calcium Hydroxylapatite 1: 2 for Mid and Lower Facial Skin Rejuvenation: Efficacy and Safety.
Rovatti PP; Pellacani G; Guida S
Dermatol Surg; 2020 Dec; 46(12):e112-e117. PubMed ID: 32205749
[TBL] [Abstract][Full Text] [Related]
2. Hyperdiluted calcium hydroxylapatite for skin laxity and cellulite of the skin above the knee: A pilot study.
Guida S; Longhitano S; Shaniko K; Galadari H; Chester J; Ciardo S; Mandel VD; Pellacani G; Urtis GG; Farnetani F
Dermatol Ther; 2020 Nov; 33(6):e14076. PubMed ID: 32713163
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of 2 Injection Techniques for Hand Biostimulatory Treatment With Diluted Calcium Hydroxylapatite.
Figueredo VO; Miot HA; Soares Dias J; Nunes GJB; Barros de Souza M; Bagatin E
Dermatol Surg; 2020 Oct; 46 Suppl 1():S54-S61. PubMed ID: 32976172
[TBL] [Abstract][Full Text] [Related]
4. Prospective Clinical Trial Evaluating the Long-Term Safety and Efficacy of Calcium Hydroxylapatite for Chest Rejuvenation.
Fabi SG; Alhaddad M; Boen M; Goldman M
J Drugs Dermatol; 2021 May; 20(5):534-537. PubMed ID: 33938688
[TBL] [Abstract][Full Text] [Related]
5. A 52-week study of safety and efficacy of calcium hydroxylapatite for rejuvenation of the aging hand.
Sadick NS
J Drugs Dermatol; 2011 Jan; 10(1):47-51. PubMed ID: 21197523
[TBL] [Abstract][Full Text] [Related]
6. Hyperdiluted calcium hydroxylapatite for the treatment of skin laxity of the neck.
Guida S; Longhitano S; Spadafora M; Lazzarotto A; Farnetani F; Zerbinati N; Pellacani G; Galadari H
Dermatol Ther; 2021 Sep; 34(5):e15090. PubMed ID: 34363289
[TBL] [Abstract][Full Text] [Related]
7. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
Lizzul PF; Narurkar VA
J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
[TBL] [Abstract][Full Text] [Related]
8. Restoring jawline contour with calcium hydroxylapatite: A prospective, observational study.
Baspeyras M; Dallara JM; Cartier H; Charavel MH; Dumas L
J Cosmet Dermatol; 2017 Sep; 16(3):342-347. PubMed ID: 28675618
[TBL] [Abstract][Full Text] [Related]
9. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
[TBL] [Abstract][Full Text] [Related]
10. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen.
Lapatina NG; Pavlenko T
J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
Jansen DA; Graivier MH
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
[TBL] [Abstract][Full Text] [Related]
12. Global Consensus Guidelines for the Injection of Diluted and Hyperdiluted Calcium Hydroxylapatite for Skin Tightening.
Goldie K; Peeters W; Alghoul M; Butterwick K; Casabona G; Chao YYY; Costa J; Eviatar J; Fabi SG; Lupo M; Sattler G; Waldorf H; Yutskovskaya Y; Lorenc P
Dermatol Surg; 2018 Nov; 44 Suppl 1():S32-S41. PubMed ID: 30358631
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of Radiesse® (calcium hydroxylapatite): evidence and recommendations for the body.
Galadari H; Guida S
Int J Dermatol; 2024 Jul; 63(7):881-889. PubMed ID: 38390986
[TBL] [Abstract][Full Text] [Related]
14. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
Tzikas TL
Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
Beer K; Yohn M; Cohen JL
J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
[TBL] [Abstract][Full Text] [Related]
16. Calcium hydroxyl-apatite (Radiesse) for the correction of periorbital hollows, dark circles, and lower eyelid bags.
Bernardini FP; Cetinkaya A; Devoto MH; Zambelli A
Ophthalmic Plast Reconstr Surg; 2014; 30(1):34-9. PubMed ID: 24398484
[TBL] [Abstract][Full Text] [Related]
17. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
Van Loghem JAJ
J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
[TBL] [Abstract][Full Text] [Related]
18. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
Jacovella PF
Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
[TBL] [Abstract][Full Text] [Related]
19. Expanding Treatment Options for Injectable Agents.
Goldberg DJ; Bass LM; Fitzgerald R; Graivier MH; Lorenc ZP
Aesthet Surg J; 2018 Apr; 38(suppl_1):S1-S7. PubMed ID: 29897519
[TBL] [Abstract][Full Text] [Related]
20. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
Carruthers A; Liebeskind M; Carruthers J; Forster BB
Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
